1.90 USD
▼+0.07-2.56%
盘后 1.81 -7.08%
2026-08-03
市值
$796.09K
市盈率
—
EPS
-63.78
股息率
—
52 周区间
1.50 – 94.60
成交量
637.57K
Beta
-0.26
目标价
60.00
52W 低 1.5052W 高 94.60
价格走势
公司简介
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre...